In 2025, RECOVER used many different study methods to understand who is most impacted by Long COVID and why the condition develops. In 2025, the RECOVER Initiative continued to make […]
Characterization of PASC and investigation of biomarkers: Insights from the RECOVER adult cohort
RECOVER researchers shared how biomarkers and the RECOVER-Adult Long COVID Research Index can help researchers understand, diagnose, prevent, and treat Long COVID. During the February 11th RECOVER Research Review (R3) […]
Long COVID trajectories in the RECOVER-Adult US cohort
Tanayott Thaweethai, Sarah E. Donohue, , et. al. Nature Communications volume 16, Article number: 9557 (2025) Abstract Longitudinal trajectories of Long COVID remain ill-defined, yet are critically needed to advance clinical trials, patient care, and public health […]
Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort
Nature Communications volume 16, Article number: 9557 (2025) Abstract Longitudinal trajectories of Long COVID remain ill-defined, yet are critically needed to advance clinical trials, patient care, and public health initiatives for millions of individuals with […]
Data-driven RECOVER research produces new discoveries about Long COVID.
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person […]
Therapeutic Strategies and Clinical Trials in Long COVID: Anticoagulants, Fibrinolytics, Endothelial Support, Immunomodulators, and RECOVER Protocols
Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is a chronic multisystem condition affecting millions globally. Despite its prevalence, therapeutic options […]
COVID Research Gaps and Future Directions: Standardization, Longitudinal Recovery, AI-Driven Biomarkers, and Policy Reform
Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), remains a poorly defined and under-researched condition affecting millions globally. Despite its prevalence, […]
Data-driven RECOVER research produces new discoveries about Long COVID.
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person […]
Data-driven RECOVER research produces new discoveries about Long COVID.
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person […]
Long COVID Now: A Special Report
Five years after the pandemic hit, questions remain about how and why millions of Americans are still struggling with long-term disease. Michele G. Sullivan, Health Central According to a June 2024 […]